Percutaneous Approach to Transitional Cell Carcinoma of the Upper Urinary Tract
暂无分享,去创建一个
[1] A. Zietman,et al. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. , 2004, The Journal of urology.
[2] J. Huguet,et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. , 2004, The Journal of urology.
[3] G. MacLennan,et al. Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. , 2003, Journal of Urology.
[4] M. Goel,et al. Percutaneous management of renal pelvic urothelial tumors: long-term followup. , 2003, The Journal of urology.
[5] U. Studer,et al. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. , 2002, The Journal of urology.
[6] T. Uchida,et al. Intravesical instillation of bacille Calmette-Guérin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. , 2002, Urology.
[7] N. Terada,et al. Intrarenal bacillus Calmette‐Guérin therapy for carcinoma in situ of the upper urinary tract: long‐term follow‐up and natural course in cases of failure , 2001, BJU international.
[8] R. Kapoor,et al. Transitional-cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. , 2001, Journal of endourology.
[9] A. Patel,et al. The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma , 2001, BJU international.
[10] M. Blute,et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. , 1999, Urology.
[11] G. Chen,et al. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. , 2000, The Journal of urology.
[12] N. Nonomura,et al. Bacillus Calmette–Guérin Perfusion Therapy for the Treatment of Transitional Cell Carcinoma in situ of the Upper Urinary Tract , 2000, European Urology.
[13] Arthur D. Smith,et al. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. , 2000, The Urologic clinics of North America.
[14] T. Deguchi,et al. Bacillus Calmette–Guérin instillation treatment for carcinoma in situ of the upper urinary tract , 2000, BJU international.
[15] P. Teillac,et al. Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome. , 2000, The Journal of urology.
[16] S. Rüsch-Gerdes,et al. Sensitivity of BCG to Modern Antibiotics , 1999, European Urology.
[17] F. Marshall,et al. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. , 1999, Journal of endourology.
[18] M. Geisinger,et al. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. , 1999, The Journal of urology.
[19] G. Fuchs,et al. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. , 1998, The Journal of urology.
[20] M. Bibbo,et al. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. , 1997, The Journal of urology.
[21] N. Bodsworth,et al. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group. , 1997, Genitourinary medicine.
[22] M. Bibbo,et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. , 1997, The Journal of urology.
[23] L. Martínez-Piñeiro,et al. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. , 1996, The Journal of urology.
[24] M. Igawa,et al. Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. , 1996, British journal of urology.
[25] D. Dearnaley,et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. , 1996, The Journal of urology.
[26] G. H. Weiss,et al. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. , 1995, The Journal of urology.
[27] K. Delaere,et al. Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. , 1995, British journal of urology.
[28] R. Low,et al. Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. , 1995, The Journal of urology.
[29] C. Powell,et al. Track infiltration following percutaneous resection of renal pelvic transitional cell carcinoma. , 1994, British journal of urology.
[30] G. Bellman,et al. Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. , 1994, The Journal of urology.
[31] J. R. Sharpe,et al. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. , 1993, The Journal of urology.
[32] R. Clayman,et al. Laparoscopic nephroureterectomy: initial clinical case report. , 1991, Journal of laparoendoscopic surgery.
[33] A. Wein,et al. The management of transitional cell carcinoma in solitary renal units. , 1991, The Journal of urology.
[34] K. Wishnow,et al. Long-term serum creatinine values after radical nephrectomy. , 1990, Urology.
[35] U. Studer,et al. Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. , 1989, The Journal of urology.
[36] J. Huffman,et al. Endoscopic Diagnosis and Treatment of Upper Tract Urothelial Tumors , 1987 .
[37] E. Orihuela,et al. Percutaneous management of renal pelvic tumors: a treatment option in selected cases. , 1987, The Journal of urology.
[38] E. Pontes,et al. Percutaneous management of upper tract transitional cell carcinoma. , 1986, The Journal of urology.
[39] H. Herr. Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. , 1985, The Journal of urology.
[40] W. Whitmore,et al. Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report , 1985, Cancer.
[41] J. Young,et al. Bilateral primary carcinoma of the ureter: topical intraureteral thiotepa. , 1984, The Journal of urology.
[42] H. W. Ferris,et al. Papillomatous Tumor of the Renal Pelvis Associated with Similar Tumors of the Ureter and Bladder. Review of Literature and Report of Two Cases1 , 1934 .